Ibiamox 500mg 12 Capsules

Active Ingredient: Amoxicillin • Ear, nose, and throat infections (pharyngitis/tonsillitis, otitis media, rhinosinusitis): Immediate-release: Treatment of infections due to beta-lactamase-negative Streptococcus spp (alpha- and beta-hemolytic isolates only), Streptococcus pneumoniae, Staphylococcus spp., or Haemophilus influenzae. • Genitourinary tract infections: Immediate-release: Treatment of infections of the genitourinary tract due to beta-lactamase-negative Escherichia coli, Proteus mirabilis, or Enterococcus faecalis. • Helicobacter pylorieradication: Immediate-release: Eradication of H. pylori to reduce the risk of duodenal ulcer recurrence as a component of combination therapy in patients with active or 1 year history of duodenal ulcer disease. • Lower respiratory tract infections (including pneumonia): Immediate-release: Treatment of infections of the lower respiratory tract due to beta-lactamase-negative Streptococcusspp. (alpha- and beta-hemolytic strains only), Streptococcus pneumoniae, Staphylococcus spp., or H. influenzae. • Pharyngitis and tonsillitis: Extended-release: Treatment of tonsillitis and/or pharyngitis due to Streptococcus pyogenes in adults and pediatric patients ≥12 years. • Skin and skin structure infections: Immediate-release: Treatment of infections of the skin and skin structure due to beta-lactamase-negative Streptococcus spp. (alpha- and beta-hemolytic strains only), Staphylococcus spp., or E. coli.